ChemCatBio is a U.S. Department of Energy national lab-led research and development consortium dedicated to identifying and overcoming catalysis challenges for the conversion of biomass and waste resources into fuels, chemicals, and materials.
By leveraging unique lab capabilities and public-private partnerships, we seek to accelerate the catalyst-process development cycle, resulting in rapid transition of research and development (R&D) discoveries and growth of the bioeconomy in the United States.
Learn more about our existing R&D projects and partnerships.
Join us for our next webinar on August 12! Jack Ferrell of the National Renewable Energy Laboratory will discuss the different types of membrane electrode assemblies (MEAs) employed in low-temperature electrochemical CO2 utilization. The architectures of both proton exchange membrane and anion exchange membrane MEAs will be explored in detail, and the advantages and limitations of each type will be presented. Get more information and register today.
Miss a ChemCatBio webinar? Recordings of all webinars are available to view online at any time. Get more information about future presentations and get caught up with previous webinars that discuss existing ChemCatBio R&D projects and public-private partnerships.
ChemCatBio recently launched CatCost™, a free online catalyst cost estimation tool that incorporates innovative decision-making logic and industry-standard estimation methods into an intuitive, user-friendly tool. Try CatCost today and watch one of the tutorial videos to get started.
Work with Us to Solve Your Catalysis ChallengesContact Us
Various mechanisms exist to leverage our unique capabilities and expertise through public-private partnerships. Contact us today to find out how.
ChemCatBio provides streamlined access to intellectual property. All participants of ChemCatBio have collectively negotiated CRADA and Intellectual Property (IP) Management Plan templates. These agreements allow industry to partner with the national labs and easily access IP that results from those engagements. Under the CRADA, IP ownership follows inventorship, with the industrial partner having a right to negotiate an exclusive license to IP developed with the ChemCatBio consortium.
Recent ChemCatBio research enables the conversion of light oxygenates into fuels and chemicals.
Single‐Step Conversion of Methyl Ethyl Ketone to Olefins over ZnxZryOz Catalysts in WaterRead More
Multi-Scale Simulation of Reaction, Transport and Deactivation in a SBA-16 Supported Catalyst for the Conversion of Ethanol to ButadieneRead More
Methanol to High-Octane Gasoline within a Market-Responsive Biorefinery Concept Enabled by CatalysisRead More